LAB vs REG · rev $174.4M vs P/E 34, $12.93B cap
Standard Biotools Inc (LAB) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
REG does not have a complete income-statement cache yet.
LAB currently screens at market cap $317.1M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the LAB and REG stock pages for the full models.
Not investment advice.